핵의학

본문글자크기
  • 2015년 10월호
    Additional Prognostic Value of SUVmax Measured by F-18 FDG PET/CT over Biological Marker Expressions in Surgically Resected Cervical Cancer Patients

    부산의대 / 윤만수, 김성장*

  • 출처
    Oncol Res Treat
  • 등재일
    2015
  • 저널이슈번호
    38(9):413-6. doi: 10.1159/000438959. Epub 2015 Aug 17
  • 내용

    바로가기  >

    Abstract

    PURPOSE:

    We compared the prognostic ability of the maximum standardized uptake value (SUVmax) and various biological marker expressions to predict recurrence in patients with surgically resected cervical cancer.

    METHODS:

    A retrospective review identified 60 patients with cervical cancer who received [18F]fluorodeoxyglucose positron emission tomography/computed tomography (F-18 FDG PET/CT) at the time of the diagnosis of cancer. The SUVmax, expressions of carbonic anhydrase-IX (CA-IX), glucose transporter 1 (GLUT-1), and vascular endothelial growth factor (VEGF), and known prognostic factors were investigated.

    RESULTS:

    The median follow-up time was 22.2 months (range 3.4-43.1 months). Using univariate analyses, the stage (stage II, p = 0.0066), SUVmax (> 6, p = 0.027), parametrial involvement (p < 0.0001), and positivity for CA-IX (p = 0.0191) were associated with recurrences of cervical cancer. With the Cox proportional hazard regression model, the SUVmax was a potent predictor for disease-free survival (DFS).

    CONCLUSION:

    Although CA-IX expression was related to DFS in the current study, the potent predictor for DFS was SUVmax. Therefore, SUVmax is of greater prognostic value than biological marker expression in patients with surgically resected cervical cancer.

    Author information 

    Yun MS1, Kim SJ, Pak K, Lee CH.

    1Department of Obstetrics &amp; Gynecology, Pusan National University Hospital, Busan, Republic of Korea. 

  • 덧글달기
    덧글달기
       IP : 3.145.167.176

    등록